Khurram Jamil, Chief Medical Officer: Galectin Therapeutics GALT Sell · Filed 24/12/26

Trade details

Type: Insider sale
Amount: $12,015.52
Shares · price: 13,654 sh · $0.88 a share
Held after: 26,346 sh
Stock: Galectin Therapeutics GALT
Person: Khurram JamilChief Medical Officer
Trade date: 24/12/23
Filed: 24/12/26
Days to filing: 3 days

Sold 34.1% of holdings

Share of holding sold: 34.1%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/23~25/01/22

Khurram Jamil's recent trades

Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$239.2K
47,467 sh
$239.2K
Filed 06/30
Traded 06/29
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$12.7K
2,533 sh
$12.7K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$10.2K
2,037 sh
$10.2K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$341.4K
68,287 sh
$341.4K
Filed 06/26
Traded 06/26
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$23.7K
7,557 sh
$23.7K
Filed 06/25
Traded 06/23